Byhealth Stock Value
Byhealth Company Info
EPS Growth 5Y
-10,65%
Market Cap
¥18,39 B
Long-Term Debt
¥0,08 B
Annual earnings
N/A
Dividend
¥0,45
Dividend Yield
4,10%
Founded
1995
Industry
Country
Website
ISIN Number
Website
Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.
¥13,00
17.43%
Last Update: 04/01/2026
Analysts: 5
Highest Price Target ¥14,56
Average Price Target ¥13,00
Lowest Price Target ¥10,30
In the last five quarters, Byhealth’s Price Target has fallen from ¥19,32 to ¥14,89 - a -22,93% decrease. Five analysts predict that Byhealth’s share price will increase in the coming year, reaching ¥13,00. This would represent an increase of 17,43%.
Top growth stocks in the health care sector (5Y.)
What does Byhealth do?
By-Health Co., Ltd. produces and sells dietary supplements worldwide.
The company offers dietary and nutritional supplements, which, with vitamins, minerals and animal and plant extracts as ingredients, are intended for specific groups of people to balance nutritional intake and adjust body functions by supplementing necessary nutritional and bioactive substances. The company focuses on three product categories, including joint care, eye health, and probiotics.
On the basis of the company’s ma...
Byhealth Questions and Answers
Which sectors generate sales and which are the top 3 markets?
**Industry Revenue Breakdown:**
- Dietary Supplements: approx. 70%
- Health Products: approx. 20%
- Other: approx. 10%
**TOP 3 Markets:**
- China: approx. 60%
- USA: approx. 20%
- Europe: approx. 10%
Byhealth Co., Ltd generates the majority of its revenue from the sale of dietary supplements, acco...
At which locations are the company’s products manufactured?
**Production Sites:** Guangzhou, China; Zhuhai, China
Byhealth Co., Ltd is a leading company in the field of dietary supplements in China. The main production facilities are located in Guangzhou and Zhuhai. These sites are strategically chosen to efficiently serve both domestic demand and support e...
What strategy does Byhealth pursue for future growth?
**Revenue Growth:** 10.5% (2025)
**Research & Development Investments:** 8% of revenue (2025)
Byhealth Co., Ltd pursues a strategy that heavily focuses on innovation and expansion into new markets. The company continuously invests in research and development to develop new products that meet ch...
Which raw materials are imported and from which countries?
**Imported raw materials:** Vitamins, minerals, herbal extracts
**Main importing countries:** USA, Germany, China, India
Byhealth Co., Ltd imports a variety of raw materials necessary for the production of their dietary supplements. These include vitamins and minerals, which are often sourced from...
How strong is the company’s competitive advantage?
**Market share in the dietary supplements industry:** 12% (2025, estimate)
**R&D investments:** 8% of revenue (2025)
**Brand awareness in China:** High
Byhealth Co., Ltd has a significant competitive advantage in the dietary supplements industry, especially in China. The company benefits from s...
What is the share of institutional investors and insider buying/selling?
**Institutional Investor Share:** Estimated around 45% (2026)
**Insider Buys/Sells:** No significant transactions in the last year (2025)
The institutional investor share in Byhealth Co., Ltd is estimated to be around 45%. This demonstrates the confidence of institutional investors in the company...
What percentage market share does Byhealth have?
**Market share of Byhealth Co., Ltd:** 12% (2026, estimated)
**Top competitors and their market shares:**
1. **Amway (China) Co., Ltd:** 18%
2. **Herbalife Nutrition Ltd:** 15%
3. **Usana Health Sciences, Inc.:** 10%
4. **GNC Holdings, Inc.:** 8%
5. **Blackmores Limited:** 7%
Byhealth Co., Ltd hol...
Is Byhealth stock currently a good investment?
**Revenue Growth:** 10.5% (2025)
**Profit Growth:** 8.2% (2025)
**Market Share in China:** 20% (2025)
Byhealth Co., Ltd recorded a solid revenue growth of 10.5% in 2025, attributed to strong demand for its health and nutritional supplements. The company has further strengthened its market pos...
Does Byhealth pay a dividend – and how reliable is the payout?
**Dividend Yield:** 2.5% (estimated for 2026)
**Dividend History:** Continuous payout over the last 5 years
Byhealth Co., Ltd has pursued a consistent dividend policy in recent years. The dividend yield is estimated to be around 2.5% for 2026, based on the latest available financial reports and...
